Maria Cristina Bonferoni Selected Research

Chitosan

4/2021	A Composite Nanosystem as a Potential Tool for the Local Treatment of Glioblastoma: Chitosan-Coated Solid Lipid Nanoparticles Embedded in Electrospun Nanofibers.
1/2021	Electrospun Scaffolds in Periodontal Wound Healing.
4/2020	Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting.
4/2020	Norfloxacin-Loaded Electrospun Scaffolds: Montmorillonite Nanocomposite vs. Free Drug.
12/2019	Dual-Functioning Scaffolds for the Treatment of Spinal Cord Injury: Alginate Nanofibers Loaded with the Sigma 1 Receptor (S1R) Agonist RC-33 in Chitosan Films.
7/2019	Chitosan/Glycosaminoglycan Scaffolds: The Role of Silver Nanoparticles to Control Microbial Infections in Wound Healing.
1/2019	Hyaluronic acid and chitosan-based nanosystems: a new dressing generation for wound care.
3/2018	Freeze dried chitosan acetate dressings with glycosaminoglycans and traxenamic acid.
2/2018	Association of Alpha Tocopherol and Ag Sulfadiazine Chitosan Oleate Nanocarriers in Bioactive Dressings Supporting Platelet Lysate Application to Skin Wounds.
10/2017	Chitosan Ascorbate Nanoparticles for the Vaginal Delivery of Antibiotic Drugs in Atrophic Vaginitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Cristina Bonferoni Research Topics

Disease

15	Wounds and Injuries (Trauma) 01/2021 - 01/2007
6	Skin Ulcer 01/2017 - 01/2007
5	Neoplasms (Cancer) 09/2021 - 10/2017
4	Infections 07/2019 - 01/2008
2	Wound Infection (Wound Infections) 04/2020 - 07/2019
2	Ulcer 01/2019 - 04/2012
2	Mucositis 03/2014 - 09/2011
1	Glioblastoma (Glioblastoma Multiforme) 04/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Periodontitis 01/2021
1	Periodontal Pocket (Periodontal Pockets) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 04/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2019
1	Esophagitis 02/2019
1	Stomatitis 02/2019
1	Ischemia 01/2019
1	Diabetic Foot 01/2019
1	Burns 01/2019
1	Inflammation (Inflammations) 01/2019
1	Leg Ulcer 01/2019
1	Hemorrhage 03/2018
1	Congenital Heart Defects (Congenital Heart Defect) 02/2018
1	Lymphatic Metastasis 01/2018
1	Atrophic Vaginitis 10/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2016
1	Eye Infections 01/2016
1	Arthritis (Polyarthritis) 10/2015

Drug/Important Bio-Agent (IBA)

17	ChitosanIBA 04/2021 - 01/2007
6	Pharmaceutical PreparationsIBA 09/2021 - 01/2008
5	PowdersIBA 01/2017 - 01/2014
4	Chondroitin Sulfates (Chondroitin Sulfate)IBA 04/2020 - 02/2018
4	Hyaluronic Acid (Hyaluronan)IBA 04/2020 - 01/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 02/2011
4	Silver Sulfadiazine (SSD)FDA LinkGeneric 02/2018 - 05/2013
3	Lipid NanoparticlesIBA 04/2021 - 05/2013
3	Biopolymers (Biopolymer)IBA 01/2021 - 01/2017
3	AlginatesIBA 12/2019 - 01/2014
3	Glutamic Acid (Glutamate)FDA Link 02/2018 - 05/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2017 - 05/2013
2	GelatinIBA 01/2021 - 02/2018
2	Norfloxacin FDA Link 04/2020 - 01/2019
2	Poloxamer (Poloxamer 407)IBA 01/2019 - 03/2014
2	Oleic Acid (Oleate)IBA 02/2018 - 01/2018
2	AntioxidantsIBA 02/2018 - 01/2007
2	Ophthalmic Solutions (Eye Drops)IBA 01/2016 - 04/2012
2	Vancomycin FDA LinkGeneric 01/2014 - 01/2008
1	Cisplatin (Platino)FDA LinkGeneric 09/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2021
1	gellan gumIBA 01/2021
1	Sigma-1 ReceptorIBA 01/2021
1	Polysaccharides (Glycans)IBA 04/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	SilverIBA 07/2019
1	GlycosaminoglycansIBA 07/2019
1	Bentonite (Montmorillonite)IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	alpha-Tocopherol FDA Link 02/2018
1	Tocopherols (Tocopherol)IBA 02/2018
1	Sulfadiazine (Sulphadiazine)FDA Link 02/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Volatile Oils (Essential Oils)IBA 01/2018
1	LipidsIBA 01/2018
1	Olive OilIBA 01/2018
1	Nanoparticle Drug Delivery SystemIBA 01/2018
1	Eucalyptus OilIBA 01/2018
1	PolyphenolsIBA 10/2017
1	OligosaccharidesIBA 01/2017
1	PectinsIBA 07/2016
1	Sericins (Sericin)IBA 03/2016
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2016
1	Excipients (Suspending Agents)IBA 01/2016
1	GelsIBA 03/2014
1	chitosan lactateIBA 03/2014
1	GlycerophosphatesIBA 03/2014
1	platelet-derived growth factor ABIBA 01/2014
1	Silver CompoundsIBA 05/2013
1	CelluloseIBA 05/2013
1	UCON 50-HB-5100 (F127)IBA 09/2011
1	carbopol 940 (sodium polyacrylate)IBA 02/2011
1	CyclodextrinsIBA 01/2008
1	gamma-cyclodextrinIBA 01/2008
1	ChlorhexidineIBA 01/2007
1	PolymersIBA 01/2007

Therapy/Procedure

7	Therapeutics 04/2020 - 01/2007
3	Drug Therapy (Chemotherapy) 09/2021 - 02/2019
2	Radiotherapy 09/2021 - 02/2019
1	Intravenous Administration 09/2021
1	Precision Medicine 04/2020
1	Liver Transplantation 04/2020